论文部分内容阅读
FDA于2008-12-01发布的文件中确认,诺华AG公司生产的复方抗疟药Coartem(蒿甲醚和本芴醇的复方制剂)有效,而且极少引起严重不良反应。
The FDA’s 2008-12-01 document confirms that Coartem (a combination of artemether and lumefantrine) produced by Novartis AG is effective and causes very few serious side effects.